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Abstract
The nitroxide, Tempol, can protect tissue from oxidative damage by removing superoxide and by oxidizing Fe(II) to
Fe(III), thus decreasing formation of the hydroxyl radical. However, long-term exposure to Tempol can damage cells. The
oxidation of Fe could have profound effects on Fe metabolism in cells, yet this has not been previously studied. In the present
investigation, the effects of Tempol on the synthesis of the Fe storage protein, ferritin, and its ability to store Fe were studied
in cultured lens epithelial cells (LEC). In addition, the effects of short- and long-term Tempol treatment on the resistance of
LEC to oxidative stress were determined. Tempol had a clear dose-dependent inhibitory effect on ferritin synthesis noted at 6
h. By 20 h, ferritin synthesis returned toward normal levels. However, Fe incorporation into ferritin was decreased by almost
90% by the highest dose of Tempol, even at the 20-h time point. The decrease in Fe incorporation into ferritin was
accompanied by a significant increase in the LMW pool of Fe. After short-term (4 h) treatment with Tempol, LEC were
protected against the toxic effects of tertiary butyl hydroperoxide. However, after longer term treatment (20 h), Tempol itself
had a toxic effect and did not afford protection. Indeed, at the higher doses, Tempol significantly reduced the ability of the
cells to withstand oxidative stress. The redistribution of Fe within the cell after 20 h of Tempol treatment appears to render
the cells more vulnerable to oxidative stress. The deleterious effects of Tempol on LEC are likely due to its effects on Fe
metabolism, perhaps by reducing the availability of Fe for incorporation into ferritin and Fe-dependent enzymes as well as
enlarging a low molecular weight pool of Fe which may be capable of catalyzing damaging free radical reactions. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
The nitroxide, Tempol, has been shown to protect
cells from oxidative damage [1,2]. Neutrophil and
hydrogen peroxide mediated DNA damage in plas-
macytoma cells was prevented by Tempol [3]. Tem-
pol can also reduce the amount of damage to the
myocardium in a model of ischemia and reperfusion
[4]. Several studies have clearly shown that short-
term exposure to Tempol can protect the ocular crys-
talline lens from damage due to X-irradiation and
hydrogen peroxide [5^7]. Several antioxidant mecha-
nisms have been proposed to account for these pro-
tective e¡ects. Tempol can act as a mimic of super-
oxide dismutase [8] and it can oxidize Fe(II) to
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Fe(III) preventing the redox cycling of Fe thereby
inhibiting production of damaging free radicals [9].
Perturbation of the redox state of Fe within cells
could have serious consequences for Fe metabolism.
However, the e¡ects of Tempol on Fe uptake and
storage have not been studied. Excess Fe taken up
by cells is stored in a non-reactive form in ferritin.
This storage capacity is believed to protect cells
against oxidative damage [10]. Ferritin synthesis is
regulated at the translational level by changes in
the intracellular concentration of Fe [11] and the re-
dox state of the cell [12]. Nitroxides, such as Tempol,
could have signi¢cant e¡ects on ferritin synthesis and
alter cellular Fe metabolism with deleterious conse-
quences. Indeed, in a recent study, it was reported
that long-term exposure to Tempol resulted in cell-
cycle disruption and apoptosis [13].
Oxidative damage to the ocular crystalline lens is a
hallmark of cataractogenesis [14]. Since virtually all
oxidative damage to cells is catalyzed by Fe, it is
essential to understand the processes underlying Fe
metabolism, uptake, storage, utilization and e¥ux in
this tissue. Since Fe metabolism is in£uenced by its
redox state, which Tempol has the capacity to alter,
this nitroxide provides a useful tool for studies of Fe
metabolism.
Because of its protective e¡ects, Tempol has been
proposed as a useful antioxidant in clinical circum-
stances [15,16]. Reports of the negative e¡ect of
Tempol on cell growth [13] make it important to
determine how long-term exposure to this compound
a¡ects Fe metabolism and the ability of cells to with-
stand oxidative stress. In the present study, we have
found that Tempol profoundly alters Fe metabolism
in cells and decreases ferritin synthesis. Short-term
exposure results in protection of the cells from oxi-
dative stress as has been shown by others; however,
long-term exposure to Tempol is toxic and results in
an exacerbation of peroxide-induced cell damage.
2. Materials and methods
2.1. Cell culture
Canine lens epithelial cells (LEC) were obtained
from mixed breed dogs which were killed at the local
animal shelter (Wake County, NC). Brie£y, after
enucleation, the lenses were dissected out of the
globe and the anterior capsule of the lens, which
contains adherent epithelial cells, was removed and
placed in a tissue culture dish containing Dulbecco’s
modi¢ed Eagle’s medium (DMEM; Gibco-
BRL)+10% fetal bovine serum (Hyclone) and anti-
biotic^antimycotic (Gibco) as previously described
[17]. After the attached epithelial cells grew out
from the capsule onto the plate, the cells were dis-
persed by trypsinization and reseeded onto the same
plate and grown to con£uence. At this time, the cells
were removed by trypsinization and plated onto ei-
ther 6-, 12- or 96-well plates for the experiments. The
experiments commenced when the cells again reached
con£uence (within 5^7 days).
2.2. Measurement of de novo ferritin synthesis
Cells were washed twice with methionine-free, se-
rum-free DMEM and then incubated in this medium
with 50 WCi of 35S-methionine (speci¢c activity 1155
Ci/mmol) for 6 or 20 h with or without Tempol,
ascorbic acid or dehydroascorbic acid as described
in the ¢gure legends. At the end of the incubation
period, the cells were rinsed twice with ice-cold PBS
and then lysed with 250 Wl of 0.05 M Tris/HCl bu¡er
(pH 8.0) containing 0.15 M NaCl, 100 Wg/ml PMSF,
1 Wg/ml aprotinin, 0.02% sodium azide and 1% Tri-
ton X-100. Ten Wl of the lysate was precipitated with
TCA for determination of total incorporation of 35S-
methionine into cellular proteins. Ferritin was immu-
noprecipitated from 200 Wl of the cell lysates with
goat anti-horse ferritin antibody (ICN, Costa Mesa,
CA, USA) and subsequent incubation (30 min) with
Pansorbin (Calbiochem, La Jolla, CA, USA). The
antibody^antigen complex was then pelleted by cen-
trifugation and ferritin released by boiling for 5 min
in denaturing, reducing SDS^PAGE loading bu¡er.
The samples were then electrophoresed on a 15%
SDS^PAGE gel. In some cases, there was complete
separation of the H and L bands, but in others, the
gels were not run for enough time to e¡ect a clear
and total separation. We did not intend to quantitate
changes in each band, so when there was separation,
we added the radioactivity found in each band to-
gether to obtain the total amount incorporated into
ferritin. After drying, the radioactivity in the gels was
counted in an electronic radioactivity detector (Pack-
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ard-Canberra, Rockville, MD, USA). The gels were
then exposed to ¢lm and the autoradiograph images
were digitized using a Hewlett-Packard scanner and
annotated with Microsoft Powerpoint.
2.3. Ferritin ELISA
Total ferritin concentration in the cells was deter-
mined by a simple sandwich ELISA as described
previously [17]. Samples used in this assay were the
remaining 15 Wl of the acetone precipitated proteins
obtained in the Fe incorporation experiments. Assay
plates were coated with goat anti-horse ferritin (ICN
Biomedical). After blocking with PBS+1% gelatin
and washing with PBS, samples and standards (dog
ferritin, New England Immunology Associates) were
added to the plate and incubated at 37‡C for 1 h.
After washing, HRP-labeled goat anti-horse ferritin
was added to each well and incubated for 1 h at
room temperature. ABTS substrate was then added
and color allowed to develop for 2^3 h. The optical
density was then read at 405 nm in a 7520 Micro-
plate Reader (Cambridge Technology).
2.4. 59Fe uptake and incorporation into ferritin
Fe uptake by the LEC was determined by incuba-
tion of the cells with 59Fe-labeled transferrin (Tf).
Human apoTf (Boehringer Mannheim) was satu-
rated with 59Fe-nitrilotriacetic acid as previously de-
scribed [18]. LEC were rinsed and preincubated for
1 h in serum free DMEM in order to remove serum
Tf that might be bound to or cycling through the
cells. Labeled Tf (5.2 WM) was added to the medium
with the treatments as described in the ¢gure legends.
After treatment, the cells were rinsed twice with ice-
cold PBS and lysed with 500 Wl of a hypotonic 10 mM
Tris/HCl bu¡er (pH 7.4) containing 100 Wg/ml PMSF
and 1 Wg/ml aprotinin. Total 59Fe uptake was deter-
mined by counting the lysates in a gamma counter
(1480 Wallac Wizard, Wallac). The lysates were then
centrifuged at 30 000Ug for 30 min. Proteins in the
supernatant were precipitated with 320‡C acetone
and recovered by centrifugation at 15 000Ug. The
dried protein pellet was resuspended in 30 Wl PBS.
Fifteen microliters of this resuspension was mixed
with an equal volume of non-denaturing, non-
reducing PAGE loading bu¡er and electrophoresed
on an 8% PAGE gel. The gels were dried and the
radioactivity in the bands was quantitated, auto-
radiographed and imaged as described above in Sec-
tion 2.2.
2.5. Cytotoxicity assay
The basis of the cytotoxicity assay used here (the
MTT (3-[4,5-dimethylthiazol-2-yl-2,5-diphenyltetra-
zolium bromide) assay) is the ability of living cells
to convert this water-soluble tetrazolium salt to an
insoluble purple formazan by cleavage of the tetra-
zolium ring by dehydrogenase enzymes. Dead cells
do not catalyze this reaction. Therefore the amount
of purple color developed is directly proportional to
the number of metabolizing cells present. LEC were
seeded in 96-well plates and were incubated with
Tempol for 4 or 20 h and then exposed to tertiary
butyl hydroperoxide at concentrations ranging from
100 to 500 WM for an additional 20 h. At the end of
the incubation, the cells were rinsed twice and the
medium replaced with DMEM+serum, without the
treatments. MTT was then added (60 Wg/well) and
incubated with the cells for 4 h. The medium was
then removed and the insoluble purple formazan
solubilized with 0.04 N HCl in isopropyl alcohol.
The absorbance was then read at 550 nm in a micro-
plate reader (Cambridge Technology).
In a parallel set of experiments, cells were seeded
in 12-well plates and grown to con£uence. The cells
were treated exactly as above for the MTT experi-
ments. At the end of the incubation period, the cells
were removed by trypsinization and counted on a
hemacytometer.
3. Results
Tempol decreased de novo ferritin synthesis almost
50% (Fig. 1). When synthesis of ferritin was greatly
increased due to treatment with ferric ammonium
citrate (FAC), Tempol decreased the FAC e¡ect.
The inhibitory e¡ect of Tempol on ferritin synthe-
sis was more signi¢cant at 6 h than 20 h at all con-
centrations (Fig. 2), with the peak inhibitory e¡ect
occurring at 0.6 mM, higher concentrations were no
more e¡ective. The total cellular concentration of
ferritin was strikingly reduced with 0.3 mM Tempol,
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higher concentrations were not more e¡ective. After
20 h exposure, both de novo ferritin synthesis and
total ferritin concentration are still reduced at all
concentrations of Tempol above 0.3 mM; however,
they have recovered in comparison to the 6-h expo-
sure time.
We have previously shown that ascorbic acid
greatly increases de novo ferritin synthesis [10].
Therefore it was of interest to determine if Tempol
could reverse ascorbic acid’s stimulatory e¡ect on
ferritin synthesis. Incubation of the cells with ascor-
bic acid and its oxidized form (dehydroascorbic acid)
for 6 h both increased de novo ferritin synthesis (Fig.
3). While ascorbic acid was able to somewhat over-
come Tempol’s inhibitory e¡ect, dehydroascorbic
acid was not. It was possible that the ability of as-
corbic acid to partially reverse the Tempol e¡ect was
due to its direct reduction of Tempol. This would
also explain the lack of e¡ectiveness of dehydroas-
Fig. 1. The e¡ect of Tempol (T) on de novo ferritin synthesis
with and without upregulation by ferric ammonium citrate
(FAC). LEC were incubated for 6 h with FAC (10 Wg/ml) and
or Tempol (0.5 mM) in serum-free, methionine-free DMEM
containing 35S-methionine (50 WCi/750 Wl ; speci¢c activity, 1155
Ci/mmol). At the end of this incubation period, cells were lysed,
ferritin was immunoprecipitated from the lysate and run on re-
ducing a 15% SDS^PAGE gel. Radioactivity in the ferritin
bands was counted on an electronic radioactivity detector (In-
stant Imager, Packard-Canberra). The radioactivity in the H
and L bands was added together and the total CPM are pre-
sented in the histogram below the autoradiograph of a repre-
sentative gel. The histogram bars represent the mean þ S.E.M.
of four experiments.
Fig. 2. The e¡ect of increasing dose of Tempol on de novo fer-
ritin synthesis and total ferritin concentration in LEC after 6
and 20 h of treatment. LEC were incubated for 6 or 20 h in se-
rum-free, methionine-free DMEM containing 35S-methionine
with or without Tempol at the indicated concentration. Cells
were subsequently lysed, ferritin immunoprecipitated and run
on a 15% SDS^PAGE gel. For measurement of the e¡ects of
Tempol on total ferritin concentration in the cells, LEC were
incubated for 6 or 20 h in serum free DMEM with Tempol at
the indicated concentrations. The cells were then lysed and fer-
ritin concentration measured by ELISA. In each case, the re-
sults are presented as a percent of control (non-Tempol treated)
values. The histogram bars represent the mean þ S.E.M. of four
experiments.
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corbic acid in reversing the inhibitory e¡ect of Tem-
pol. In order to examine this possibility more closely,
in another set of experiments, ascorbic acid and
Tempol were preincubated together for 5 min before
being added to the LEC. This preincubation, which
causes the complete reduction of Tempol [7], com-
pletely abolished the e¡ects of Tempol on de novo
ferritin synthesis (Fig. 4A). Therefore, the e¡ects of
Tempol on ferritin synthesis are likely due to its oxi-
dative capacity.
The oxidative capacity of Tempol can alter the
redox state of Fe within cells. Since in vitro studies
indicate that ferritin cannot obtain Fe from Fe(III)
complexes, the e¡ects of Tempol on Fe incorporation
into ferritin were examined. Tempol greatly reduced
Fe incorporation, while preincubation of Tempol
with ascorbic acid completely blocked this inhibitory
e¡ect (Fig. 4B).
In order to further delineate the e¡ects of Tempol
on Fe metabolism in LEC, the cells were exposed to
increasing doses of this compound and the protein
precipitate of the cell lysate was electrophoresed for
determination of the fate of 59Fe within these cells
(Fig. 5). After 6 and 20 h, Fe incorporation into
ferritin was greatly decreased at all doses, even the
lowest dose (0.15 mM). This decrease is in spite of
the fact that ferritin synthesis is on the rebound at
the 20-h time point. In addition, this decrease in Fe
incorporation is not due to a decrease in Fe uptake
into the cells since the total amount of 59Fe taken up
into the cells from transferrin was una¡ected by
Tempol treatment. After incubation of cells with
59Fe-transferrin, a small amount of radioactivity is
found in a di¡use low molecular weight band, which
we have termed the low molecular weight (LMW)
pool. This pool is similar to that described by Vyoral
and Petrak [19]. Tempol has dramatic, time-depen-
dent e¡ects on this pool. After 20-h incubation with
Tempol, the pool is substantially enlarged (200^
300%; Fig. 5). However, short-term treatment with
Tempol (6 h) had the opposite e¡ect, decreasing the
size of this pool from 533 CPM (control) to 128, 105,
44 CPM (0.15, 0.3, 0.6 mM Tempol, respectively;
data not shown in ¢gure).
Fig. 3. The e¡ect of Tempol on ascorbic acid stimulation of de novo ferritin synthesis. LEC were incubated for 6 h with dehydroas-
corbic acid (dha; 0.5 mM), ascorbic acid (asc; 0.5 mM), and or Tempol (T; 0.5 mM) for 6 h in serum-free, methionine-free DMEM
containing 35S-methionine. At the end of this incubation period, cells were lysed, ferritin immunoprecipitated and run on a 15% SDS^
PAGE gel. CPM are presented in the histogram below the autoradiograph of a representative gel. The histogram bars represent the
mean þ S.E.M. of three experiments.
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The e¡ect of Tempol on Fe incorporation could be
due to decreased ferritin synthesis and therefore a
reduced amount of ferritin available for Fe incorpo-
ration. It also could be due to decreased Fe uptake
into this protein or by removal of Fe which has been
deposited in the mineral core. Tempol is capable of
entering the mineral core of ferritin [20], therefore it
could mobilize Fe after incorporation. To investigate
this possibility cells were incubated with 59Fe-trans-
ferrin for 20 h, then exposed to Tempol (0.5 mM) for
another 20 h. The 59Fe content of ferritin was re-
duced by 35% after Tempol exposure (Fig. 6), indi-
cating the possibility that Tempol can remove Fe
from ferritin. It is also possible that after 20 h of
incubation, some of the 59Fe present in ferritin has
been recycled and that Tempol simply blocks the
uptake of this recycled 59Fe into ferritin.
A protective role for Tempol against oxidative in-
sult has been documented by many investigators.
Most of these studies documented only short-term
e¡ects of Tempol (less than 4 h). However, a recent
investigation clearly showed that Tempol could be
toxic when incubated with cells for a longer period
of time [13]. Based on our ¢ndings that Tempol al-
ters Fe metabolism in a time-dependent manner we
decided to assess the e¡ect of both short- and long-
term exposure to Tempol on the ability of LEC to
withstand oxidative stress. Therefore LEC were
treated with Tempol for 4 or 20 h and then chal-
lenged with bolus doses of tertiary butyl hydroper-
oxide (TBHP) for an additional 20 h. After these
incubations, metabolic activity of the cells was deter-
mined by the MTT assay (Fig. 7). As shown by
others, a 4-h preincubation with Tempol completely
blocked the damaging e¡ects of 400 and 500 WM
TBHP. However, a 20-h preincubation with Tempol
not only failed to protect the cells against TBHP
Fig. 4. The e¡ect of reduction of Tempol with ascorbic acid on
de novo ferritin synthesis and Fe incorporation into ferritin.
(A) LEC were treated for 6 h with ascorbic acid (asc; 0.5 mM),
Tempol (T; 0.5 mM) or Tempol (0.5 mM) which had been re-
duced by preincubation with ascorbic acid (0.5 mM) for 5 min
prior to addition. These treatments took place in serum-free,
methionine-free DMEM containing 35S-methionine (50 WCi/750
Wl ; speci¢c activity, 1155 Ci/mmol). At the end of the incuba-
tion period, cells were lysed, ferritin immunoprecipitated and
run on a 15% SDS^PAGE gel. (B) LEC were treated for 6 h
with ascorbic acid (0.3 mM), Tempol (0.3 mM) or Tempol (0.3
mM) which had been preincubated with ascorbic acid (0.3 mM)
for 5 min prior to addition. These treatments took place for 20
h in serum-free DMEM with 59Fe-labeled transferrin (5.2 WM).
After incubation, the cells were lysed and the lysate centrifuged.
Proteins in the supernate were precipitated with cold acetone
and dissolved in non-denaturing PAGE loading bu¡er and elec-
trophoresed in an 8% PAGE gel. In both experiments, radioac-
tivity in the ferritin bands was counted on an electronic radio-
activity detector (Instant Imager, Packard-Canberra). CPM are
presented in the histogram below the autoradiograph of a rep-
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toxicity, but actually worsened the damage. In a par-
allel set of experiments, cells were exposed to Tempol
and TBHP and then cells were counted. The results
of these experiments (data not shown) mirrored the
experiments in which metabolic activity was the end
point measured, that is the cell counts were signi¢-
cantly lower when the metabolic activity measured
was lower.
4. Discussion
Tempol can provide protection against oxidative
stress in numerous in vivo and in vitro models.
This protection is believed to be due to its ability
to dismutate superoxide and to oxidize Fe(II) to
Fe(III) [8,9], which blocks the formation of reactive
oxygen species. Although Tempol’s e¡ects on Fe me-
tabolism are likely to be profound, there have been
no studies to date speci¢cally addressing how Fe me-
tabolism within cells is a¡ected by this compound.
The importance of the Fe storage protein, ferritin, to
normal lens metabolism is underscored by the recent
¢ndings that a mutation which causes altered ferritin
synthesis results in early bilateral cataracts in hu-
mans [21,22]. We therefore undertook the current
study to determine how Fe metabolism and the abil-
ity of the LEC to withstand oxidative challenge is
a¡ected by this oxidant after both short- and long-
term exposure.
Ferritin is the main iron storage protein in cells
and its synthesis is regulated at the translational level
by iron regulatory proteins (IRP1 and -2). These
proteins bind to an iron responsive element (IRE)
Fig. 5. The e¡ect of increasing concentration of Tempol on 59Fe incorporation into ferritin and a low molecular weight Fe pool. LEC
were incubated for 20 h with Tempol at di¡erent concentrations in serum free DMEM with 59Fe-labeled transferrin (5.2 WM). After
incubation, the cells were lysed and the lysate centrifuged. Proteins in the supernate were precipitated with cold acetone and dissolved
in non-denaturing PAGE loading bu¡er and electrophoresed in an 8% PAGE gel. Radioactivity in the ferritin band and in the low
molecular weight pool (LMWP) was counted on an electronic radioactivity detector (Instant Imager, Packard-Canberra). The results
are presented as percent of control (non-Tempol treated). CPM are presented in the histogram below the autoradiograph of a repre-
sentative gel. The histogram bars represent the mean þ S.E.M. of six experiments.
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in the 5P-untranslated region of ferritin mRNA.
Binding to this IRE prevents translation of ferritin.
The binding a⁄nity of IRP1 is in£uenced by Fe con-
centration and redox conditions [12]. When the cell is
Fe replete the IRP contains an Fe/sulfur cluster
which allows this protein to act enzymatically as a
cytosolic aconitase and inhibits the binding of the
IRP to the IRE, allowing ferritin synthesis to pro-
ceed. Upon Fe deprivation, the Fe/sulfur cluster dis-
assembles, aconitase activity is lost, binding to the
IRE is enabled and ferritin synthesis is inhibited
[23,24].
The strong inhibitory e¡ect of Tempol on ferritin
synthesis and Fe incorporation is dependent upon its
oxidation state since reduction of Tempol by ascor-
bic acid completely blocks both of its e¡ects on these
processes. Others have shown that Fe(II) is required
for the switch to aconitase activity from IRE bind-
ing, thus enabling ferritin synthesis to proceed [24^
26]. Thus, by oxidizing Fe(II) to Fe(III), Tempol
may block the insertion of the Fe/sulfur cluster into
the IRP, resulting in increased binding to the IRE in
ferritin mRNA and dramatically decreased ferritin
synthesis. It is also possible that Tempol prevents
the synthesis of the Fe/S cluster. This is not an un-
likely scenario, since Tempol localizes to the mito-
chondria [27] where the formation of the Fe/S cluster
takes place [28]. Either of these e¡ects could account
for the results seen in the present study, that ferritin
synthesis is altered by Tempol, in a time- and dose-
dependent fashion. Tempol causes a reduction in the
size of the LMW Fe pool at the early (6-h) time
point. This is associated with a decrease in ferritin
synthesis. However, at the later (20-h) time point the
LMW Fe pool is greatly increased with a concomi-
tant increase in total ferritin levels and ferritin syn-
thesis (compared to the 6-h time point). It is there-
fore possible the Fe present in the LMW pool plays
Fig. 7. The e¡ect of Tempol on toxicity of tertiary butyl hydro-
peroxide. LEC were preincubated with Tempol for 4 h (A) or
20 h (B) and then exposed to TBHP at concentrations ranging
from 100 to 500 WM for an additional 20 h. At the end of these
incubations, the cells were rinsed and the medium replaced with
DMEM+serum, without Tempol or TBHP. Then MTT was
added and incubated with the cells for 4 h. After solubilization
of the purple formazan metabolite, the absorbance was read at
550 nm. OD readings were used as a measure of cellular meta-
bolic activity. The results presented in the histogram are the
means þ S.E.M. of 8^16 samples. *P6 0.05, signi¢cantly di¡er-
ent from the control (no Tempol, no TBHP). 7P6 0.05, signi¢-
cantly di¡erent from the TBHP (500 WM)-treated, non-Tempol-
treated cells.
Fig. 6. The e¡ects of Tempol on Fe preloaded into ferritin.
LEC were incubated with 59Fe-labeled transferrin (5.2 WM) for
20 h in serum-free DMEM. At the end of this incubation peri-
od, Tempol was added and incubated for an additional 20 h.
Then the cells were lysed and the lysate centrifuged. Proteins in
the supernate were precipitated with cold acetone and dissolved
in non-denaturing PAGE loading bu¡er and electrophoresed in
an 8% PAGE gel. Radioactivity in the ferritin band was
counted on an electronic radioactivity detector (Instant Imager,
Packard-Canberra) and is presented as the mean þ S.E.M. of
CPM from six experiments.
BBAMCR 14626 22-5-00
M. Goralska et al. / Biochimica et Biophysica Acta 1497 (2000) 51^6058
some role in regulating IRP activity and ferritin bio-
synthesis.
We have previously demonstrated that Fe taken
up from transferrin is preferentially incorporated
into newly synthesized ferritin, not into pre-existing
ferritin [18]. Therefore, the inhibition of ferritin syn-
thesis by Tempol is likely responsible for at least part
of the decreased Fe incorporation into this protein
and the concomitant accumulation of Fe in a LMW
pool at the 20-h time point. It is also possible that
Tempol prevents incorporation by oxidizing Fe since
it is not possible to load apoferritin with Fe(III)
compounds unless there is a reducing agent present
[29,30]. The increase in the amount of Fe in a low
molecular weight pool is likely the result of the inhi-
bition of Fe incorporation into ferritin, since there is
a clear relationship between the amount of Fe in
ferritin and in the LMW pool with increasing Tem-
pol concentrations. The decrease in Fe incorporation
into ferritin was not due to a Tempol-induced de-
crease in total Fe uptake, since Tempol had no e¡ect
on this parameter, instead, Tempol substantially al-
ters the distribution of Fe within the cell.
It was also possible that the increase in Fe concen-
tration in the LMW pool resulted from Tempol-in-
duced removal of Fe from ferritin, since it was pro-
posed that Tempol can enter the ferritin cavity and
perhaps mobilize Fe stored in ferritin [20]. When
cells were preincubated with 59Fe in order to load
ferritin with labeled Fe, and then exposed to Tempol,
the amount of Fe incorporated into ferritin was de-
creased and the amount of Fe in the LMW Fe pool
was increased. Although this could be interpreted as
being the result of Tempol releasing Fe from ferritin,
Tempol could block the reuptake of Fe into ferritin
from a recirculating Fe pool. Either of these mecha-
nisms of action leaves the cell with a LMW pool of
Fe which may be capable of increasing damage in the
presence of oxidative stress.
We were able to con¢rm earlier ¢ndings that
short-term exposure (4 h) to Tempol protected
the LEC from oxidative stress induced by tertiary
butyl hydroperoxide. However, long-term exposure
(s 20 h) to Tempol resulted in decreased cell viabil-
ity in control cells, and increased susceptibility to
damage caused by exposure to peroxide. In the
short-term, we noted that the LMW pool of Fe in
the cytosol was reduced to non-detectable levels by
the highest concentration of Tempol. If this pool of
Fe is capable of causing oxidative damage, then a
reduction in the size of this pool could be protective.
However, over the long term, a decrease in the pro-
duction of ferritin, inhibition of Fe incorporation
into this protein and the resulting increase in a
LMW pool of Fe could increase the potential for
creation of quantities of damaging species which
overwhelm the normal protective mechanisms of
the cell. A toxic e¡ect of Tempol upon long-term
incubation was also noted by other investigators
[13]. The long-term toxic e¡ects of Tempol itself, in
absence of additionally applied oxidative stress,
could be due to alterations in Fe metabolism in the
cells which result in altered synthesis of essential Fe-
dependent proteins.
These results have important consequences for use
of Tempol as a protective agent against oxidative
stress. Short-term exposure could be protective in
cases of ischemia reperfusion; however, long-term
exposure to even low concentrations of Tempol is
potentially highly toxic. A complete study of the
overall e¡ects of Tempol on Fe utilization by the
cell, including the synthesis of essential proteins in
the mitochondria is warranted. Tempol is likely to
be a useful tool for such studies.
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